IVERIC bio, Inc. (NASDAQ:ISEE) has a beta value of 2.19 and has seen 6,851,781 shares traded in the last trading session. The company, currently valued at $474.29 Million, closed the last trade at $5.36 per share which meant it lost -$0.5 on the day or -9.31% during that session. The ISEE stock price is -67.35% off its 52-week high price of $8.97 and 83.02% above the 52-week low of $0.91. If we look at the company’s 10-day average daily trading volume, we find that it stood at 4.78 Million shares traded. The 3-month trading volume is 980.94 Million shares.

The consensus among analysts is that IVERIC bio, Inc. (ISEE) is a Buy stock at the moment, with a recommendation rating of 1.5. None of the analysts rate the stock as a Sell, while none rate it as Overweight. None out of 2 have rated it as a Hold, with 2 advising it as a Buy. None have rated the stock as Underweight. The expected earnings per share for the stock is -$0.31.

IVERIC bio, Inc. (NASDAQ:ISEE) trade information

Despite being -9.31% in the red today, the stock has traded in the green over the last five days, with the highest price hit on Monday, Jun 22 when the ISEE stock price touched $6.74-2 or saw a rise of 20.47%. Year-to-date, IVERIC bio, Inc. shares have moved -37.53%, while the 5-day performance has seen it change -18.79%. Over the past 30 days, the shares of IVERIC bio, Inc. (NASDAQ:ISEE) have changed 27.01%. Short interest in the company has seen 597.21 Million shares shorted with days to cover at 0.61.

Wall Street analysts have a consensus price target for the stock at $14, which means that the shares’ value could jump 161.19% from current levels. The projected low price target is $13 while the price target rests at a high of $15. In that case, then, we find that the current price level is +179.85% off the targeted high while a plunge would see the stock lose 142.54% from current levels.

IVERIC bio, Inc. (ISEE) estimates and forecasts

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was +16.9% over the past 5 years. Earnings growth for 2020 is a modest -181.9% while over the next 5 years, the company’s earnings are expected to increase by 0%.

IVERIC bio, Inc. (NASDAQ:ISEE)’s Major holders

Insiders own 0.96% of the company shares, while shares held by institutions stand at 83% with a share float percentage of 83.81%. Investors are also buoyed by the number of investors in a company, with IVERIC bio, Inc. having a total of 83 institutions that hold shares in the company. The top two institutional holders are Consonance Capital Management LP with over 3.15 Million shares worth more than $10.84 Million. As of March 30, 2020, Consonance Capital Management LP held 6.27% of shares outstanding.

The other major institutional holder is VR Adviser, LLC, with the holding of over 2.59 Million shares as of March 30, 2020. The firm’s total holdings are worth over $8.9 Million and represent 5.15% of shares outstanding.

Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and Invesco Health Care Fund. As of March 30, 2020, the former fund manager holds about 2.9% shares in the company for having 1456951 shares of worth $5.01 Million while later fund manager owns 706.59 Thousand shares of worth $4.69 Million as of January 30, 2020, which makes it owner of about 1.41% of company’s outstanding stock.